All Pharma News
price-trendAsk Us
Evommune Announces Initiation of a Phase 1 Trial of its MRGPRX2 Antagonist

Evommune Announces Initiation of a Phase 1 Trial of its MRGPRX2 Antagonist
PR NEWSWIRE
18 Jan 2024
Share Share
Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration

Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration
PR NEWSWIRE
28 Nov 2023
Share Share
Evommune Announces Strategic Collaboration with Maruho to Develop MRGPRX2

Evommune Announces Strategic Collaboration with Maruho to Develop MRGPRX2
PR NEWSWIRE
27 Sep 2023
Share Share
Evommune drops IRAK4 inhibitor on phase 2 dermatitis data

Evommune drops IRAK4 inhibitor on phase 2 dermatitis data
James Waldron FIERCE BIOTECH
27 Sep 2023
Share Share
Evommune Adds Additional Investment In Series B Financing

Evommune Adds Additional Investment In Series B Financing
PR NEWSWIRE
28 Jun 2023
Share Share
Evommune Initiates Phase 2a Trial to Evaluate EVO101 in Atopic Dermatitis

Evommune Initiates Phase 2a Trial to Evaluate EVO101 in Atopic Dermatitis
PRNEWSWIRE
28 Sep 2022
Share Share
Evommune Initiates Phase 1 Study to Evaluate Safety of EVO101

Evommune Initiates Phase 1 Study to Evaluate Safety of EVO101
PRNEWSWIRE
21 Mar 2022
Share Share
Evommune Completes $83 Million Series A Financing

Evommune Completes $83 Million Series A Financing
TRIALSITENEWS
10 Sep 2021
Share Share
Evommune snags $83M for

Evommune snags $83M for "Tylenol for itch," three other programs
Kyle LaHucik FIERCEBIOTECH
09 Sep 2021
Share Share
The old Dermira team heads for clinic; takes candidates back from Eli Lilly,

The old Dermira team heads for clinic; takes candidates back from Eli Lilly,
Nicole DeFeudis ENDPTS
09 Sep 2021
Share Share